MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics, Inc. (MPLT) is a healthcare company (biotechnology) based in the United States. The share price is $6.59, down 4.49% on the day, which values the company at $366.24M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$6.59−4.49% today
Market value
$366.24M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

MapLight Therapeutics, Inc. in more detail

MPLT trades at -1.8× next year's expected earnings.

In its favour: More cash than debt.

1 of the superinvestors tracked here hold MPLT, including Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding MPLT

1 of the investors tracked here report a position in their latest 13F filing.

MapLight Therapeutics, Inc. (MPLT): questions and answers

What is MapLight Therapeutics, Inc.'s market cap?

MapLight Therapeutics, Inc. is valued at $366.24M at a share price of $6.59.

Does MPLT pay a dividend?

MapLight Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own MPLT?

In their latest quarterly filings, Julian and Felix Baker (0.1% of the portfolio) hold MPLT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “MapLight Therapeutics, Inc. (MPLT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MPLT

Underlying data: Yahoo Finance; company filings with the SEC.